1. Home
  2. ALLO vs DVS Comparison

ALLO vs DVS Comparison

Compare ALLO & DVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • DVS
  • Stock Information
  • Founded
  • ALLO 2017
  • DVS 2011
  • Country
  • ALLO United States
  • DVS Canada
  • Employees
  • ALLO N/A
  • DVS N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • DVS
  • Sector
  • ALLO Health Care
  • DVS
  • Exchange
  • ALLO Nasdaq
  • DVS Nasdaq
  • Market Cap
  • ALLO 252.9M
  • DVS 210.3M
  • IPO Year
  • ALLO 2018
  • DVS N/A
  • Fundamental
  • Price
  • ALLO $1.13
  • DVS $4.15
  • Analyst Decision
  • ALLO Strong Buy
  • DVS
  • Analyst Count
  • ALLO 10
  • DVS 0
  • Target Price
  • ALLO $8.88
  • DVS N/A
  • AVG Volume (30 Days)
  • ALLO 3.0M
  • DVS 566.9K
  • Earning Date
  • ALLO 11-06-2025
  • DVS 08-13-2025
  • Dividend Yield
  • ALLO N/A
  • DVS N/A
  • EPS Growth
  • ALLO N/A
  • DVS N/A
  • EPS
  • ALLO N/A
  • DVS N/A
  • Revenue
  • ALLO N/A
  • DVS N/A
  • Revenue This Year
  • ALLO N/A
  • DVS N/A
  • Revenue Next Year
  • ALLO $100.00
  • DVS N/A
  • P/E Ratio
  • ALLO N/A
  • DVS N/A
  • Revenue Growth
  • ALLO N/A
  • DVS N/A
  • 52 Week Low
  • ALLO $0.86
  • DVS $2.48
  • 52 Week High
  • ALLO $3.78
  • DVS $4.69
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 47.86
  • DVS 58.08
  • Support Level
  • ALLO $1.09
  • DVS $3.94
  • Resistance Level
  • ALLO $1.21
  • DVS $4.69
  • Average True Range (ATR)
  • ALLO 0.07
  • DVS 0.22
  • MACD
  • ALLO 0.01
  • DVS 0.04
  • Stochastic Oscillator
  • ALLO 33.33
  • DVS 57.14

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About DVS Dolly Varden Silver Corporation Common Shares

Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.

Share on Social Networks: